Once opened, refrigeration helps maintain stability
If you qualify, BPC-157 treatments are sourced from a licensed U.S
Postmenopausal osteoporosis (type I): After menopause, women experience a sudden drop in estrogen levels, a significant increase in osteoclast activity, accelerated bone resorption, insufficient osteoblast activity, and rapid loss of bone mass (30% -50% loss after 5-10 years of menopause), mainly in the lumbar spine and hip
When delivered via intramuscular injection, B12 energy booster shots bypass the digestive system and enter the bloodstream directlyoffering faster and more effective results
FDA - Certain Bulk Drug Substances for Use in Compounding: Lists BPC-157 with potential safety risks and lack of sufficient information
TB-500 protocols often run 4 to 8 weeks, then reassess